ASM 2023 Program
We are pleased to announce that the following speakers have confirmed their participation in the TOGA ASM 2023.
We are delighted that the two international speakers, Professors Karen Kelly and Stephen Swisher, have accepted our invitations and will be joining us in-person at the TOGA ASM.
- Prof Karen Kelly, CEO from the International Association for the Study of Lung Cancer (IASLC) who will present on Immunotherapy Past, Present and Future.
- Prof Stephen Swisher, Division Head of Surgery, the Charles A. LeMaistre Distinguished Chair in Thoracic Oncology and Professor in the Thoracic and Cardiovascular Surgery Department at MD Anderson Cancer Center who will present on immuno-oncology as it relates to surgery in early-stage disease.
We will also be joined by two other international speakers, Professor Christopher Booth and Dr Christine Berg via ‘livestream’.
- Professor Christopher Booth, Medical Oncologist from Queen’s University who will present on time toxicity in cancer treatment.
- Dr Christine Berg, Radiation Oncologist from U.S. National Cancer Institute (retired) who will present on climate change and lung cancer.
We also have an agenda full of local speakers presenting on diverse topics.
See the full program below.
Note: * The agenda topics, speakers and times provided herein may be subject to change*
- - - Wednesday, 19 July 2023 - - -
NSCLC Molecular Testing Workshop
| Time | Topic | Presented By |
|---|---|---|
| 12:00-13:00 | REGISTRATIONS | |
| 13:00-13:10 | Welcome and Introduction | Dr Rebecca Tay Medical Oncologist Royal Hobart Hospital and Icon Cancer Centre |
| 13:10-14:05 | Overview of Molecular Testing Techniques | A/Prof Trishe Leong Medical Director of Pathology & Director of Anatomical Pathology St Vincent’s Hospital Melbourne |
| 14:05-14:20 | 'Tissue is the Issue' - Optimising Tissue Sampling | Dr Tracy Leong Respiratory Physician Austin Health |
| 14:20-14:50 | AFTERNOON TEA|
| |
| 14:50-15:30 | Molecular Testing in Clinical Practice | Dr Malinda Itchins Medical Oncologist Royal North Shore Hospital, GenesisCare, and North Shore Private |
| 15:30-16:00 | Funding for NGS Molecular Testing of NSCLC in Australia | Prof Wendy Cooper Tissue Pathology and Diagnostic Oncology NSW Health Pathology Royal Prince Alfred Hospital |
| 16:00-16:15 | Molecular Testing in Regional Centres - Disparities and Overcoming the Gap | Dr Rebecca Tay Medical Oncologist Royal Hobart Hospital and Icon Cancer Centre |
| 16:15-16:30 | BREAK | |
| 16:30-17:00 | Molecular Tumour Board Case Studies | All Presenters |
| 17:00 | FINISH |
- - - Thursday, 20 July 2023 - - -
| Time | Topic | Presented By |
|---|---|---|
| 09:00-10:00 | REGISTRATIONS | |
| 09:45-10:00 | Welcome to Country | |
| 10:00-10:10 | Welcome | A/Prof Zarnie Lwin ASM Convenor Senior Medical Oncologist Royal Brisbane and Women’s Hospital & The Prince Charles Hospital University of Queensland |
| 10:10-10:30 | Opening Address | Chair: A/Prof Zarnie Lwin Rebecca Davies Consumer Advocate |
| 10:30-11:05 | Plenary: Immunotherapy (IO) Past, Present and Future | Chair: Prof Nick Pavlakis Prof Karen Kelly CEO, IASLC Professor Emeritus University of California, Davis |
| 11:05-11:40 | Plenary: Early-Stage Disease IO Current status of immuno-oncology as it relates to surgery in NSCLC | Chair: Mr Stephen Barnett Prof Stephen Swisher Head, Division of Surgery Charles A. LeMaistre Distinguished Chair in Thoracic Oncology Professor, Department of Thoracic and Cardiovascular Surgery MD Anderson Cancer Center |
| 11:40-12:00 | Time Toxicity in Cancer Treatment | Chair: A/Prof Zarnie Lwin Prof Christopher Booth Professor of Oncology and Public Health Sciences Canada Research Chair in Population Cancer Care Director, Division of Cancer Care and Epidemiology Queen's University and Kingston Health Sciences Centre |
| 12:00-12:20 | Timing of Radiation Therapy with Immunotherapy | Chair: Dr Nicholas Bucknell Dr Fiona Hegi-Johnson Radiation Oncologist Peter MacCallum Cancer Centre |
| 12:20-13:20 | LUNCH|
| |
| 13:20-13:40 | Immuno-Oncology in Mesothelioma | Chair: Prof Nick Pavlakis A/Prof Steven Kao Medical Oncology Staff Specialist, Chris O’Brien Lifehouse Clinical Associate Professor, The University of Sydney Research Fellow, Asbestos Diseases Research Institute |
| 13:40-14:00 | Survivorship Experience for People Treated with Immunotherapy or Targeted Therapy | Chair: Ms Mary Duffy AM Dr Sarah Heynemann Oncology Research Fellow St Vincent’s Hospital Melbourne |
| 14:00-14:20 | Exercise Rehabilitation Pre and Post Lung Cancer Surgery | Chair: Dr Jazmin Eckhaus A/Prof Catherine Granger Associate Professor of Physiotherapy, The University of Melbourne Head of Physiotherapy Research, The Royal Melbourne Hospital |
| 14:20-14:40 | What’s Hot in Palliative Care | Chair: Ms Mary Duffy AM A/Prof Jaclyn Yoong Medical Oncologist | Palliative Care Physician Northern Health | Monash Health |
| 14:40-15:00 | The role of a Nurse Practitioner in Rural/Regional Australia | Chair: Ms Melanie Rabbets Ms Katrina West Nurse Practitioner Peter MacCallum Cancer Centre |
| 15:00-15:30 | AFTERNOON TEA | |
| 15:30-17:30 | Oral Abstracts | Chairs: Dr Deborah Zhou / Dr Nicholas Bucknell |
| 17:30 | FINISH | |
| 18:30-22:00 | DINNER: Residence @ Grand Hyatt Melbourne |
- - - Friday, 21 July 2023 - - -
| Time | Topic | Presented By |
|---|---|---|
| 07:00-08:00 | Microsatellite Breakfast Symposium Emerging Immunotherapies: From early to late NSCLC | Chair: A/Prof Zarnie Lwin |
| 08:00-08:30 | REGISTRATIONS | |
| 08:30-08:35 | Welcome | A/Prof Zarnie Lwin ASM Convenor Senior Medical Oncologist Royal Brisbane and Women’s Hospital & The Prince Charles Hospital University of Queensland |
| 08:35-08:55 | Tackling Smoking in Indigenous Australians | Chair: A/Prof Zarnie Lwin Prof Tom Calma AO Co-Chair, Reconciliation Australia 2023 Senior Australian of the Year |
| 08:55-09:30 | Targeted Therapies – Keeping up with the Data | Chair: Prof Ben Solomon Dr Tarek Mekhail Medical Director, Thoracic Cancer Program AdventHealth Cancer Institute |
| 09:30-09:50 | Equipping the Workforce for a Lung Cancer Screening Program | Chair: Dr Sarah Heynemann A/Prof Emily Stone Deputy Chair, TOGA Board of Directors Respiratory Physician St Vincent’s Hospital Sydney |
| 09:50-10:10 | Enhancing responsiveness to immunotherapy in KRAS-mutant lung adenocarcinoma | Chair: Prof Ben Solomon A/Prof Kate Sutherland Laboratory Head The Walter and Eliza Hall Institute of Medical Research |
| 10:10-10:30 | Squamous Cell Lung Cancer – Understanding the Matrix | Chair: Prof Nick Pavlakis Dr Amelia Parker Senior Research Officer Garvan Institute of Medical Research |
| 10:30-11:00 | MORNING TEA|
| |
| 11:00-12:30 | TOGA TRIALS | Chairs: A/Prof Tom John / Dr Sarah Heynemann |
| 11:00-11:17 | ASPiRATION - An observational cohort study to assess the clinical impact of comprehensive genomic profiling in metastatic lung cancer patients | Prof Nick Pavlakis Chair, TOGA Board of Directors Medical Oncologist and Senior Staff Specialist Royal North Shore Hospital |
| 11:17-11:25 | DYNAMALK - DYNAMic ctDNA profiling in ALK+ NSCLC: a study of the AUstralian Registry and biObank of thoRacic cAncers (AURORA) | Dr Malinda Itchins Medical Oncologist Royal North Shore Hospital, GenesisCare, and North Shore Private |
| 11:25-11:45 | OCEANIC - Osimertinib plus Chemotherapy Evaluation in Adjuvant NSCLC incorporating CtDNA | A/Prof Thomas John Medical Oncologist Peter MacCallum Cancer Centre |
| 11:45-12:00 | SHERLOCK - Sotorasib witH bEvacizumab fiRst Line cOmbined with Chemotherapy for KRAS G12C NSCLC | A/Prof Chee Lee Medical Oncologist and Senior Staff Specialist St George and Sutherland Hospitals |
| 12:00-12:15 | CHEST-RT - Chemotherapy and Immunotherapy in Extensive Stage Small cell with Thoracic Radiotherapy | A/Prof Paul Mitchell Associate Professor, University of Melbourne Thoracic Oncologist, Olivia Newton-John Cancer Wellness and Research Centre Director, North-East Melbourne Integrated Cancer Service |
| 12:15-12:30 | DREAM3R - DuRvalumab (MEDI4736) with chEmotherapy as first line treAtment in advanced pleural Mesothelioma - A phase 3 Randomised trial | A/Prof Brett Hughes Senior Staff Specialist Medical Oncologist Royal Brisbane and Women’s Hospital The Prince Charles Hospital Associate Professor, University of Queensland |
| 12:30-13:30 | LUNCH | |
| 13:30-13:50 | Climate Change and Lung Cancer - Why We Need to Take Notice | Chair: A/Prof Zarnie Lwin Dr Christine Berg U.S. National Cancer Institute (retired) |
| 13:50-14:20 | TOGA Extraordinary General Meeting (EGM) (Open to only TOGA Members) | Prof Nick Pavlakis Chair, TOGA Board of Directors Medical Oncologist and Senior Staff Specialist Royal North Shore Hospital |
| 14:20-14:40 | Vision of the IASLC | Chair: Dr Rebecca Tay Prof Karen Kelly CEO, IASLC Professor Emeritus University of California, Davis |
| 14:40-15:00 | Introducing the Lung Cancer Moonshot Program | Chair: A/Prof Phillip Antippa Prof Stephen Swisher Head, Division of Surgery Charles A. LeMaistre Distinguished Chair in Thoracic Oncology Professor, Department of Thoracic and Cardiovascular Surgery MD Anderson Cancer Center |
| 15:00-16:15 | THE GREAT DEBATE ‘AI will take over lung cancer management in the future’ | Chair: Mr Stephen Barnett |
| 16:15-16:30 | Awards and Close | A/Prof Zarnie Lwin ASM Convenor Senior Medical Oncologist Royal Brisbane and Women’s Hospital & The Prince Charles Hospital University of Queensland |
| 16:30 | FINISH |
